Johnson & Johnson says in early talks to buy Swiss drug maker Actelion

121

Johnson and Johnson said on Friday that is in early converses with purchase Swiss drug maker Actelion Pharmaceuticals.

Actelion Pharmaceuticals Ltd makes high blood pressure that treat supply routes in the lung and around the heart. Johnson and Johnson, of New Brunswick, New Jersey, create medications and makes medical devices and other buyer items.

Shares of Johnson & Johnson rose 93 cents to $114 in afternoon trading Friday.